NCT04636177

Brief Summary

The proposed research is a single arm feasibility trial of pain rehabilitation virtual reality (PRVR) aimed at measuring feasibility, acceptability and utility of VR as well as changes in physical function and fear for adolescents with chronic musculoskeletal pain. The intervention includes standard physiotherapy treatment including functional goal setting and progressive exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable chronic-pain

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 13, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 19, 2020

Completed
1.3 years until next milestone

Study Start

First participant enrolled

March 10, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2024

Completed
11 months until next milestone

Results Posted

Study results publicly available

November 14, 2025

Completed
Last Updated

November 14, 2025

Status Verified

October 1, 2025

Enrollment Period

2.7 years

First QC Date

November 13, 2020

Results QC Date

August 25, 2025

Last Update Submit

October 30, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • VR Duration of Use Per Week

    This outcome is to assess Feasibility, Acceptability, and Utility of VR.

    Baseline to end of treatment across 6-8 weeks, on average

  • Participant Rated Ease of Use

    This outcome is to assess Feasibility, Acceptability, and Utility of VR.

    End of treatment at 6-8 weeks, on average

  • Participant Rated Enjoyment

    This outcome is to assess Feasibility, Acceptability, and Utility of VR.

    End of treatment at 6-8 weeks, on average

Secondary Outcomes (3)

  • Pain-related Fear and Avoidance

    Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment

  • Physical Function: Lower Extremity

    Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment

  • Physical Function: Upper Extremity

    Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment

Study Arms (2)

Pain Rehabilitation Virtual Reality (PRVR)

EXPERIMENTAL

Participants will complete VR in PT to engage participants in a series of immersive games customized to align with individual PT needs delivered over \~6-12 weeks or until clinician believes the patient is done with treatment. Patients in the PRVR arm will be given a structured HEP to practice prescribed exercises at home with integrated VR activities. PRVR participants will be allocated a VR headset for use in PT sessions and with HEP. VR will supplement treatment and be used in session (either in-person or telehealth) and at home as part of their prescribed treatment homework.

Behavioral: Pain Rehabilitation Virtual Reality (PRVR)

Standard Physiotherapy Rehabilitation (SPR)

ACTIVE COMPARATOR

Sessions are individually-tailored and based on the Guide to Physical Therapy Practice 3.0 consisting of 1) therapeutic exercise, 2) balance and proprioception, 3) strength training, and 4) use of modalities (e.g., heat/cold pack). Patients will be given a structured Home Exercise Program (HEP) with prescribed exercises for home. SPR participants will be allocated a VR headset for recreational use.

Behavioral: Standard Physiotherapy Rehabilitation (SPR)

Interventions

Participants will receive approximately 8, 1-hour physiotherapy sessions delivered over the course of 6-12 weeks. Adequate dose: 75% (6 of 8 sessions).

Pain Rehabilitation Virtual Reality (PRVR)

Participants allocated to either intervention arm will receive 8, 1-hour physiotherapy sessions delivered over the course of 6-8 weeks. Adequate dose: 75% (6 of 8 sessions).

Standard Physiotherapy Rehabilitation (SPR)

Eligibility Criteria

Age10 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • to 17 years old
  • Musculoskeletal pain (e.g. localized \[back, limb\], diffuse) not due to acute trauma (e.g. active sprain or fracture)
  • English Language Proficiency

You may not qualify if:

  • Significant cognitive impairment (e.g., brain injury)
  • Significant medical or psychiatric problem that would interfere (e.g. psychosis, suicidality)
  • Presents with a condition that interferes with virtual reality usage (e.g., history of seizure, facial injury precluding safe placement of headset, visual impairment, significant hearing impairment impact ability to follow audio instructions).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Pediatric Pain Management Clinic - Stanford Children's Health

Menlo Park, California, 94025, United States

Location

California Rehabilitation and Sports Therapy

Palo Alto, California, 94306, United States

Location

Related Publications (1)

  • Simons LE, Hess CW, Choate ES, Van Orden AR, Tremblay-McGaw AG, Menendez M, Boothroyd DB, Parvathinathan G, Griffin A, Caruso TJ, Stinson J, Weisman A, Liu T, Koeppen K. Virtual Reality-Augmented Physiotherapy for Chronic Pain in Youth: Protocol for a Randomized Controlled Trial Enhanced With a Single-Case Experimental Design. JMIR Res Protoc. 2022 Dec 12;11(12):e40705. doi: 10.2196/40705.

MeSH Terms

Conditions

Chronic PainMusculoskeletal PainFibromyalgia

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Results Point of Contact

Title
Laura E Simons
Organization
Stanford University School of Medicine

Study Officials

  • Laura Simons, PhD

    Stanford School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 13, 2020

First Posted

November 19, 2020

Study Start

March 10, 2022

Primary Completion

December 7, 2024

Study Completion

December 7, 2024

Last Updated

November 14, 2025

Results First Posted

November 14, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Individual participant data (text, tables, figures, appendices) that underlie the results reported in an article related to this trial will, after de-identification, be shared with researchers who provide a methodologically sound proposal.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Beginning 3 months and ending 5 years following article publication.
Access Criteria
Proposals should be directed to Dr. Laura Simons at lesimons@stanford.edu. To gain access, data requestors will need to sign a data access agreement with Stanford University.

Locations